Adgero Biopharmaceuticals Holdings, Inc. — Form D
Adgero Biopharmaceuticals Holdings, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-19. The offering totals $15.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-04-19
- Form: D
- Accession: 0000905718-16-001355
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $3.0M
- Remaining: $12.0M
- Investors: 39
- Date of first sale: 2016-04-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-261595
Issuer
- Name: Adgero Biopharmaceuticals Holdings, Inc.
- CIK: 0001657598
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 301 N. HARRISON ST., PRINCETON, NJ, 08540
- Phone: 609-275-6837
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| John Brancaccio | Executive Officer | San Diego, CA |
| David P Hochman | Director | New Hope, PA |
| David Hochman | Director | Cleveland, OH |
| David Hochman | Executive Officer | Cleveland, OH |
| Steve P Rychnovsky | Executive Officer | Princeton, NJ |
| Tim P McInerney | Director | Princeton, NJ |
| Frank P Pilkiewicz | Director | Princeton, NJ |
| Frank P Pilkiewicz | Executive Officer | Princeton, NJ |
| Allen P Bloom | Director | Princeton, NJ |
| Roman P Perez-Soler | Director | Princeton, NJ |
Other filings by this issuer (2)
More